Business Context and Reporting Period
Acme United Corporation filed its Form 10-K for the fiscal year ended December 31, 2023. The company supplies first aid and medical products, scissors, shears, knives, sharpening tools and related products through three reportable segments: United States, Canada and Europe. Its principal customers include mass-market and e-commerce retailers, industrial distributors, office and stationery distributors, sporting-goods stores and hardware chains.
Operations are global, with substantial sourcing from Asia and manufacturing, assembly, distribution and administrative activities in North America, Europe and Asia. The filing reports annual results; it does not provide a separately presented fourth-quarter income statement in the supplied text.
Key Financial Metrics
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Net sales | $191.5 million | $194.0 million | Down 1.3% |
| Gross profit | $72.2 million | $63.6 million | Up $8.7 million |
| Gross margin | 37.7% | 32.8% | Up 490 basis points |
| SG&A expense | $59.0 million | $57.3 million | Up 3.0% |
| Operating income | $13.2 million | $6.3 million | Up $6.9 million |
| Net interest expense | $3.0 million | $2.4 million | Up $0.6 million |
| Income before taxes | $22.7 million | $3.7 million | Up $19.1 million |
| Net income | $17.8 million | $3.0 million | Up $14.8 million |
| Basic/diluted EPS | $4.98/$4.86 | $0.86/$0.82 | Higher year over year |
| Net cash from operations | $28.9 million | $2.9 million | Up $26.0 million |
Net income and EPS benefited materially from the gain on the sale of the Camillus and Cuda product lines. The $12.6 million pretax gain increased net income by approximately $9.6 million after tax.
Product-category sales were $114.5 million for first aid and safety and $77.0 million for cutting and sharpening. Segment sales were $163.2 million in the United States, $13.9 million in Canada and $14.4 million in Europe. E-commerce represented approximately 18% of net sales.
Cash Flow, Debt and Liquidity
- Cash, cash equivalents and restricted cash totaled $5.5 million at December 31, 2023, compared with $7.6 million at year-end 2022. Cash and cash equivalents alone were $4.8 million.
- Operating cash flow was $28.9 million, supported by net income, lower receivables and inventory reductions.
- Capital expenditures were $4.7 million, compared with $4.3 million in 2022.
- The company repaid $36.8 million of revolving debt during 2023, primarily using proceeds from the Camillus and Cuda divestiture.
- Revolving credit borrowings were $13.2 million, with $51.8 million available under the $65 million facility at year-end. The facility expires May 31, 2026 and bears interest based on SOFR plus a spread that varies with leverage.
- Mortgage debt was $10.8 million at a fixed 3.8% rate, with final maturity in December 2031. Total debt, including the mortgage, was approximately $24.0 million before applicable debt issuance costs.
- Management stated that cash on hand, operating cash flow and available revolver capacity should fund planned operations for at least the next twelve months under current conditions.
- The company was in compliance with its revolving-credit covenants at December 31, 2023.
Material Changes Versus the Prior Comparable Period
- Sales declined modestly because customers reduced inventory during the first half of 2023. Europe declined 4% in U.S. dollars, Canada increased 1%, and the U.S. segment declined 1%.
- Gross margin expanded substantially due primarily to manufacturing and distribution productivity improvements and lower inbound freight costs.
- Operating income more than doubled, with the U.S. segment contributing most of the improvement. SG&A increased because of higher personnel-related costs.
- Interest expense increased as the weighted-average interest rate rose to 6.5% from 3.8%.
- Inventory declined approximately $7.9 million, or 12%, and receivables declined approximately $6.4 million. Days sales outstanding improved to 55 days from 62 days.
- The company completed a previously announced inventory-reduction program of approximately $5 million and reported annual cost savings of more than $6.5 million from productivity and cost-reduction initiatives.
- On September 27, 2023, the company acquired the assets of Hawktree Solutions, a Canadian first aid and medical supplier, and integrated the business in the fourth quarter.
- On November 1, 2023, the company sold its Camillus and Cuda hunting and fishing product lines for $19.8 million. The divested products represented approximately 6% of 2023 sales.
Outlook, Risks, Contingencies and Unusual Items
- The filing does not provide formal revenue or earnings guidance. Management expects available liquidity to support planned operations for at least twelve months, subject to current conditions.
- Key risks include inflation in labor, raw materials, freight and services; elevated interest rates; customer demand volatility; seasonality in the Westcott back-to-school business; competition; customer concentration; and reliance on third-party distributors and overseas suppliers.
- Supply-chain risks include overseas production and shipping delays, tariffs, customs and port disruptions, geopolitical conflicts, potential pandemics, labor constraints and currency fluctuations.
- Two customers each exceeded 10% of 2023 consolidated sales, representing approximately 14% and 12%. Three customers represented approximately 17%, 14% and 14% of consolidated trade receivables.
- The company identified a material weakness in internal control over financial reporting related to information-technology general controls, including change-management, logical-access and segregation-of-duties controls. Management stated that the weakness did not result in financial-statement misstatements or changes to previously released results.
- Marcum LLP issued an unqualified opinion on the financial statements but an adverse opinion on internal control over financial reporting because of the material weakness. Management expects remediation to be completed before the end of fiscal 2024, subject to successful operation and testing of the new controls.
- The remaining $750,000 contingent consideration related to the Safety Made acquisition was held in restricted cash at year-end.
- The company reported no pending material legal proceedings, no off-balance-sheet transactions and no material cybersecurity incidents to date.
Investor Verification Checklist
- Verify the sustainability of the 2023 gross-margin improvement and the reported $6.5 million of annual cost savings.
- Separate recurring operating performance from the $12.6 million pretax gain on the Camillus and Cuda divestiture.
- Monitor sales trends following the 2023 customer inventory reductions, particularly in the U.S. and European segments.
- Confirm remediation progress for the IT general-controls material weakness and whether the auditor provides a clean internal-control opinion for 2024.
- Track variable-rate interest expense, compliance with debt covenants and utilization of the $51.8 million revolver availability.
- Assess customer concentration, e-commerce performance, seasonal back-to-school demand and exposure to foreign suppliers, tariffs, freight costs and geopolitical disruptions.
- Review the terms and resolution of the $1.5 million divestiture holdback and the remaining $750,000 Safety Made contingent consideration.